At Novartis Oncology, we value social media, which allows us to engage directly with patients, families, caregivers, advocates, physicians and more.
Below you can find our current active channels. We encourage you to follow, like and interact with us on each social media platform. We will be sharing relevant updates from Novartis Oncology on a variety of topics including clinical trial data, treatment milestones, disease awareness initiatives and patient resources:
Novartis Oncology is responsible for the creation and management of these channels, which were developed to share company news and support our vision of providing assistance to people with cancer through innovation and community.
We are regularly exploring new ways to connect with the cancer community on a more personal level by utilizing new and emerging social media platforms. Please continue to visit this page for the most up-to-date list of where to find us online.
Thank you for following us on social media! We look forward to hearing from you and sharing more information and insight as we continue our fight to end cancer.
We appreciate hearing from you and will do our best to respond, however, we would like to remind you that the pharmaceutical industry is one that is highly regulated. As a result, we can’t engage in sensitive topics, or discussions about products or treatment options and may not be able to respond to content that is profane, defamatory, violates the social platform rules, etc.
Accounts that Novartis Oncology follows or is followed by are not an indication of Novartis’ endorsement of these accounts or the content they produce.
If you believe that you have experienced any medical side effects or reactions from a Novartis product you should consult your physician, pharmacist or other healthcare professional immediately. You can also report these to us directly using the information found on Novartis.com.
For more information, please refer to our community guidelines, which you can find below: